Cecilie Heramb

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers

Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud et al. · BMC Cancer · 2017 · 95 citations · Full text

Medicine, Genetics, Oncology +12

BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway

Cecilie Heramb, Teresia Wangensteen, Eli Marie Grindedal et al. · Hereditary Cancer in Clinical Practice · 2018 · 39 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer

Jan Norum, Eli Marie Grindedal, Cecilie Heramb et al. · ESMO Open · 2018 · 26 citations · Full text

Pharmacy, Genetics, Oncology +15

Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway

Eli Marie Grindedal, Kjersti Jørgensen, Pernilla Turunen Olsson et al. · Familial Cancer · 2020 · 25 citations · Full text

Medicine, Genetics, Oncology +9

The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry

Eli Marie Grindedal, Harald Aarset, Inga Bjørnevoll et al. · Hereditary Cancer in Clinical Practice · 2014 · 17 citations · Full text

Life Sciences, Genetics, Oncology +17